DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

terreus infection. Antimicrob Agents Chemother, 2004, 48:
3217–3225.
Ullmann AJ, Cornely OA, Burchardt A, et al. Pharmacokinetics,
safety and efficacy of posaconazole in patients with persistent
febrile neutropenia or refractory invasive fungal infections.
Antimicrob Agents Chemother, 2006, 50:658–666.
Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole
for prophylaxis in severe graft-versus-host disease.
N Engl J Med, 2007, 356:335–347.
van der Horst CM, Saag MS, Cloud GA, et al. Treatment of cryptococcal
meningitis associated with the acquired immunodeficiency
syndrome. National Institute of Allergy and Infectious
Diseases Mycoses Study Group and AIDS Clinical Trials
Group. N Engl J Med, 1997, 337:15–21.
Vazquez JA, Sobel JD. Anidulafungin: A novel echinocandin.
Clin Infect Dis, 2006, 43:215–222.
Villanueva A, Arathoon EG, Gotuzzo E, et al. A randomized
double-blind study of caspofungin versus amphotericin for
the treatment of candidal esophagitis. Clin Infect Dis, 2001,
33:1529–1535.
Wagner C, Graninger W, Presterl E, Joukhadar C. The
echinocandins: Comparison of their pharmacokinetics, pharmacodynamics
and clinical applications. Pharmacology, 2006,
78:161–177.
Walsh TJ, Karlsson MO, Driscoll T, et al. Pharmacokinetics and
safety of intravenous voriconazole in children after single- or
multiple-dose administration. Antimicrob Agents Chemother,
2004a, 48:2166–2172.
Walsh TJ, Pappas P, Winston DJ, et al., for the National Institute
of Allergy and Infectious Diseases Mycoses Study Group.
Voriconazole compared with liposomal amphotericin B for
empirical antifungal therapy in patients with neutropenia and
persistent fever. N Engl J Med, 2002, 346:225–234.
Walsh TJ, Teppler H, Donowitz GR, et al. Caspofungin versus
liposomal amphotericin B for empirical antifungal therapy in
patients with persistent fever and neutropenia. N Engl J Med,
2004, 351:1391–1402.
White MH, Bowden RA, Sandler ES, et al. Randomized, doubleblind
clinical trial of amphotericin B colloidal dispersion vs.
amphotericin B in the empirical treatment of fever and neutropenia.
Clin Infect Dis, 1998, 27:296–302.
Wiederhold NP, Lewis JS 2nd. The echinocandin micafungin: A
review of the pharmacology, spectrum of activity, clinical efficacy
and safety. Expert Opin Pharmacother, 2007, 8:1155–1166.
Wiederhold NP, Lewis RE. The echinocandin antifungals: An
overview of the pharmacology, spectrum and clinical efficacy.
Expert Opin Invest Drugs, 2003, 12:1313–1333.
Wingard JR, White MH, Anaissie E, et al. A randomized, doubleblind
comparative trial evaluating the safety of liposomal
amphotericin B versus amphotericin B lipid complex in the
empirical treatment of febrile neutropenia. Clin Infect Dis,
2000, 31:1155–1163.
Zonios DI, Bennett JE. Update on azole antifungals. Semin
Respir Crit Care Med, 2008, 29:198–210.
Zonios DI, Gea-Banacloche J, Childs R, Bennett JE. Hallucinations
during voriconazole use. Clin Infect Dis, 2008, 47:e7–10.
1591
CHAPTER 57
ANTIFUNGAL AGENTS